Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

President’s Perspective: The ACR and ARHP Advance Rheumatology Through International Collaboration

Audrey B. Uknis, MD, and Jan K. Richardson, PT, PhD, OCS  |  Issue: August 2013  |  August 1, 2013

Dr. Uknis
Dr. Uknis

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Dr. Richardson
Dr. Richardson

Global Rheumatology Community
The 2012 ILAR Executive Committee (left to right): Rohini Handa, MD, (APLAR); Maxime Dougados, MD, (EULAR); Zhanguo Li, MD, PhD, (APLAR); Maurizio Cutolo, MD, (EULAR); Mark Andrejeski (ACR); Audrey Uknis, MD, (ACR); Heinz Merchesi (EULAR); Aicha Ladjouze-Rezig, MD, (AFLAR); Omondi Oyoo, MD, (AFLAR); John Reveille, MD, (PANLAR); James O’Dell, MD, (ACR); Carlos Pineda, MD, (PANLAR); and Antonio Ximenes, MD, (PANLAR).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Clarification: Sunshine Act

Last month’s “President’s Perspective” covered some commonly asked questions about the Physician Payment Sunshine Act. We’d like to provide some additional information on one of the questions.

Q: I am an investigator on a study. Will my payments be reported?

A: Yes, payments or transfer of value that may be related to research funding is reportable.

Addition: Only the study’s principal investigator (PI) is linked to a study and included in the reporting. The manufacturer will report the total payment, who they made it to (contract research organization or university, site), and the information on the PI.

This month, it is a great honor to share my column with the ARHP President, Jan K. Richardson, PT, PhD, OCS, to discuss the ACR’s and ARHP’s strides in international collaboration. In rheumatology, we have the team of physicians, scientists, and health professionals working together to improve the care of our patients with rheumatic disease. We understand that collaboration is imperative to achieving best outcomes. In some cases, a collaboration can serve to share knowledge or experience, and in other cases, de novo projects may benefit from a collaborative approach. The ACR/ARHP collaboration has really advanced our field in myriad ways—our educational programs, our journals, our critical committee work.

The ACR’s mission is to Advance Rheumatology!, and part of our new strategic plan is a specific goal to increase the ACR’s international outreach and presence. We have heard from our international members about a desire to stay connected and to share our programs and products with their local communities—sometimes to provide key support in developing nations. We have heard from our colleagues representing international societies and leagues against rheumatism around the world, with a clear sense that collaboration will enhance the strength of our field—the science, the clinical care, the perceived value of rheumatology. To meet this critical strategic goal, we are collaborating with numerous rheumatology leagues and national organizations around the world, establishing new connections and strengthening time-honored efforts.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:EULAR/OtherMeeting ReportsPresident's Perspective Tagged with:ACR/ARHPEULARInternationalrheumatology

Related Articles

    The Pathway to Success

    August 1, 2008

    Collaboration with our partners is key to ensuring a bright future for the ACR

    It’s A Small World after All

    August 1, 2011

    Advancing rheumatology throughout the world

    A New Focus of International Rheumatology

    December 1, 2008

    International collaboration through ILAR promotes health equity in rheumatology

    Get to Know the ARP’s Power Couple

    January 17, 2019

    Bob and Jan Richardson’s separate paths to physical therapy and rheumatology involve wrestling and horses—although not at the same time. Their intertwining stories also involve a fair amount of serendipity. Mr. Bob Richardson For Bob Richardson, PT, MEd, the path started in the late 1950s, when he was wrapping up a fulfilling college wrestling career…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences